IL136462A0 - Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases - Google Patents
Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseasesInfo
- Publication number
- IL136462A0 IL136462A0 IL13646298A IL13646298A IL136462A0 IL 136462 A0 IL136462 A0 IL 136462A0 IL 13646298 A IL13646298 A IL 13646298A IL 13646298 A IL13646298 A IL 13646298A IL 136462 A0 IL136462 A0 IL 136462A0
- Authority
- IL
- Israel
- Prior art keywords
- combination
- proliferative diseases
- antineoplastic drugs
- treating proliferative
- benzocycloheptapyridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99602797A | 1997-12-22 | 1997-12-22 | |
US14352998A | 1998-08-28 | 1998-08-28 | |
US18196998A | 1998-10-29 | 1998-10-29 | |
PCT/US1998/026224 WO1999032114A1 (en) | 1997-12-22 | 1998-12-21 | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL136462A0 true IL136462A0 (en) | 2001-06-14 |
Family
ID=27385940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13646298A IL136462A0 (en) | 1997-12-22 | 1998-12-21 | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1041985B1 (es) |
JP (1) | JP4502503B2 (es) |
KR (1) | KR100700907B1 (es) |
CN (1) | CN1129431C (es) |
AR (1) | AR017440A1 (es) |
AT (1) | ATE317697T1 (es) |
AU (1) | AU756762B2 (es) |
BR (1) | BR9814419A (es) |
CA (1) | CA2315693C (es) |
CL (1) | CL2007001889A1 (es) |
CO (1) | CO5080764A1 (es) |
CZ (1) | CZ298511B6 (es) |
DE (1) | DE69833509T2 (es) |
DK (1) | DK1041985T3 (es) |
ES (1) | ES2255196T3 (es) |
HU (1) | HUP0102473A3 (es) |
IL (1) | IL136462A0 (es) |
MY (1) | MY137303A (es) |
NO (1) | NO326832B1 (es) |
NZ (1) | NZ504928A (es) |
PE (1) | PE20000042A1 (es) |
PT (1) | PT1041985E (es) |
SK (1) | SK285584B6 (es) |
TW (1) | TW581763B (es) |
WO (1) | WO1999032114A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2787327B1 (fr) * | 1998-12-21 | 2003-01-17 | Aventis Pharma Sa | Compositions contenant des inhibiteurs de farnesyle transferase |
RU2298417C2 (ru) * | 1999-11-09 | 2007-05-10 | Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) | Продукт, включающий ингибитор трансдукции сигналов гетеротримерных протеинов g в комбинации с другим цитостатическим средством, для терапевтического применения при лечении рака |
WO2001045740A2 (en) * | 1999-12-22 | 2001-06-28 | The Government Of The United States, Department Of Health And Human Services | Compositions and methods for treatment of breast cancer |
AU2001256166A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives |
JP2003525236A (ja) * | 2000-02-29 | 2003-08-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ビンカアルカロイドとのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤 |
WO2001064197A2 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
CA2397446A1 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica Inc. | Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
JP2003525246A (ja) * | 2000-02-29 | 2003-08-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 白金化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤 |
AU2001239275A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
TWI310684B (en) | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
WO2002056884A2 (en) * | 2001-01-22 | 2002-07-25 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
DE60230017D1 (de) * | 2001-02-15 | 2009-01-08 | Janssen Pharmaceutica Nv | Farnesyl-protein-transferase hemmer in kombination mit antiöstrogenen |
US20030185831A1 (en) * | 2001-11-30 | 2003-10-02 | Schering Corporation | Methods of treating cancer using an FPT inhibitor and antineoplastic |
CN1849122A (zh) * | 2001-12-03 | 2006-10-18 | 先灵公司 | Fpt抑制剂与至少两种抗肿瘤药在治疗癌症中的用途 |
WO2008022535A1 (fr) * | 2006-08-09 | 2008-02-28 | Tian Jin Tasly Group Co., Ltd. | Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique |
CN105198758A (zh) * | 2015-09-22 | 2015-12-30 | 湖南大学 | 一种高纯度(z)-他莫昔酚的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
EP0563134B1 (en) * | 1990-12-18 | 1996-06-19 | The Wellcome Foundation Limited | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
JP2767176B2 (ja) * | 1992-12-15 | 1998-06-18 | 大塚製薬株式会社 | 抗癌剤 |
US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
WO1997005902A1 (fr) * | 1995-08-09 | 1997-02-20 | Banyu Pharmaceutical Co., Ltd. | Composition medicinale |
AU730194B2 (en) * | 1995-12-22 | 2001-03-01 | Merck Sharp & Dohme Corp. | Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
PL189698B1 (pl) * | 1996-03-12 | 2005-09-30 | Pg Txl Co | Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania |
JP2000507584A (ja) * | 1996-04-03 | 2000-06-20 | メルク エンド カンパニー インコーポレーテッド | ファルネシル―タンパク質転移酵素の阻害剤 |
WO1997038697A1 (en) * | 1996-04-15 | 1997-10-23 | The Trustees Of The University Of Pennsylvania | Sensitization of cells to radiation and chemotherapy |
CA2251955A1 (en) * | 1996-04-18 | 1997-10-23 | Nancy E. Kohl | A method of treating cancer |
EP0934270A1 (en) * | 1996-05-30 | 1999-08-11 | Merck & Co., Inc. | A method of treating cancer |
WO1998032376A1 (en) * | 1997-01-29 | 1998-07-30 | Picker Medical Systems, Ltd. | Predictive bolus tracking |
SK285969B6 (sk) * | 1997-02-18 | 2007-12-06 | Canji, Inc. | Prípravky na liečenie cicavčích nádorových alebo hyperproliferatívnych buniek |
-
1998
- 1998-12-21 BR BR9814419-7A patent/BR9814419A/pt not_active Application Discontinuation
- 1998-12-21 JP JP2000525105A patent/JP4502503B2/ja not_active Expired - Fee Related
- 1998-12-21 CN CN98813742A patent/CN1129431C/zh not_active Expired - Fee Related
- 1998-12-21 KR KR1020007006938A patent/KR100700907B1/ko not_active IP Right Cessation
- 1998-12-21 PT PT98963829T patent/PT1041985E/pt unknown
- 1998-12-21 HU HU0102473A patent/HUP0102473A3/hu unknown
- 1998-12-21 AT AT98963829T patent/ATE317697T1/de not_active IP Right Cessation
- 1998-12-21 AR ARP980106565A patent/AR017440A1/es unknown
- 1998-12-21 IL IL13646298A patent/IL136462A0/xx unknown
- 1998-12-21 MY MYPI98005809A patent/MY137303A/en unknown
- 1998-12-21 CO CO98075842A patent/CO5080764A1/es unknown
- 1998-12-21 WO PCT/US1998/026224 patent/WO1999032114A1/en active IP Right Grant
- 1998-12-21 ES ES98963829T patent/ES2255196T3/es not_active Expired - Lifetime
- 1998-12-21 EP EP98963829A patent/EP1041985B1/en not_active Expired - Lifetime
- 1998-12-21 CZ CZ20002236A patent/CZ298511B6/cs not_active IP Right Cessation
- 1998-12-21 SK SK898-2000A patent/SK285584B6/sk not_active IP Right Cessation
- 1998-12-21 CA CA2315693A patent/CA2315693C/en not_active Expired - Fee Related
- 1998-12-21 PE PE1998001263A patent/PE20000042A1/es not_active Application Discontinuation
- 1998-12-21 NZ NZ504928A patent/NZ504928A/xx unknown
- 1998-12-21 AU AU19072/99A patent/AU756762B2/en not_active Ceased
- 1998-12-21 TW TW087121355A patent/TW581763B/zh not_active IP Right Cessation
- 1998-12-21 DE DE69833509T patent/DE69833509T2/de not_active Expired - Lifetime
- 1998-12-21 DK DK98963829T patent/DK1041985T3/da active
-
2000
- 2000-06-21 NO NO20003229A patent/NO326832B1/no not_active IP Right Cessation
-
2007
- 2007-06-27 CL CL2007001889A patent/CL2007001889A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9700939A0 (en) | Compounds and methods for the treatment of cancer | |
ZA971937B (en) | Combinations for treatment of proliferative diseases. | |
PL330814A1 (en) | Compounds for and methods of delivering pharmaceutical preparations and their application | |
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
IL136462A0 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
EP1077704A4 (en) | COMBINATION THERAPY FOR TREATING DEPRESSION | |
GB9812056D0 (en) | Pharmaceutical composition for treatment of ibd and rbd | |
HK1042825A1 (zh) | 治療氣道疾病的化合物和方法以及氣道藥物的給藥方法 | |
IL136515A0 (en) | Combination effective for the treatment of impotence | |
HUP0100012A3 (en) | Use for macrolides for the treatment of cancer and macular degeneration | |
ZA989556B (en) | Benzoxazine derivatives their preparation and their therapeutic application | |
IL211081A0 (en) | Methods and devices for providing prolonged drug therapy | |
IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
HK1063004A1 (en) | Oxalatoplatin and 5-fluorouracil for combination therapy of cancer | |
GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
HUP0001263A3 (en) | Methods of therapeutic administration of anti-cd4ol compounds | |
IL115320A0 (en) | Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases | |
AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
IL121329A0 (en) | A pharmaceutical composition for the treatment of cancer | |
HUP9904173A3 (en) | Pharmaceutical composition for treating viral diseases | |
GB2344586B (en) | Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds | |
SG65766A1 (en) | Composition for preventing and treating gingival diseases | |
ZA984650B (en) | Intratumoral administration of triphenylethylenes for the treatment of cancer | |
AU6126498A (en) | Method for the treatment of drug addiction and homeopathic remedy | |
KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia |